After propensity score matching, statin users and non-users were not statistically different in gender, age, the prevalence of dyslipidemia, diabetes, coronary artery disease, glucose metabolism profile (including fasting blood glucose, insulin level, HbA1c and HOMA-IR) and concomitant medications (all p > 0.05) (Table 3). Here, INS is linked to metabolic syndrome.